Relapsed or Refractory Mantle Cell Lymphoma (MCL)
3 clinical trials · Condition
◉ Watch Relapsed or Refractory Mantle Cell Lymphoma (MCL)
| Record | Firm | Date |
|---|---|---|
| Ph2 Gem/Nov/Rituxan Rel/Ref MantleCell (NCT00656084) | US Oncology Research | 2004-12-01 |
Track Relapsed or Refractory Mantle Cell Lymphoma (MCL) automatically
Every clearance here is in the API, with alerts when new ones post.